Northvane

Cost and access

How many plasma exchange sessions will I need, and what will the series cost?

The number depends on why you are treated. For serious rheumatic disease, plasma exchange usually runs 5 to 10 sessions every 2 to 3 days. Private longevity clinics sell series of 2 to 6, often followed by maintenance, at prices from $3,500 for one low-volume session to $59,995 for advanced packages. No trial has defined a best longevity schedule.

Nov 17, 2026Updated Nov 18, 20268 min read

A paper calendar and an open notebook on a wooden desk in soft daylight
Photo: Artsy Crafty, CC0 1.0 · source

For a diagnosed disease, the illness sets the course: in serious rheumatic disease, therapeutic plasma exchange (TPE) usually means 5 to 10 sessions every 2 to 3 days. Private longevity clinics typically sell series of 2 to 6 sessions, at prices from $3,500 for one low-volume session to $59,995 for one clinic's advanced protocols. No trial has shown that any number of sessions helps people live longer or stay healthier.

How many plasma exchange sessions do people usually get?

In hospital medicine the disease sets the number of sessions. In private longevity care the clinic sets it, often with open-ended maintenance afterward.

The American Society for Apheresis grades the evidence condition by condition. Its current guideline contains 93 fact sheets and 183 graded and categorized indications. The American College of Rheumatology gives one example of a disease-driven schedule. For serious complications of refractory lupus, antiphospholipid syndrome and similar conditions, plasma exchange is "usually done every 2–3 days over the course of 5–10 sessions." That schedule treats an active disease. It is not a longevity schedule.

Private clinics describe their own series. Global Apheresis in Mill Valley, California, says "most patients undergo a series of 4–6" sessions, and that longevity patients often begin with an initial series and transition to periodic maintenance. MDLifespan lists 3 or 5 sessions for its "Improving Your Biological Age" protocol, and 5 for its brain and heart protocols. Extension Health in New York says some conditions may require ongoing treatment, and acknowledges that the evidence for several uses is still emerging.

These are clinic protocols. No study has defined how often, or for how long, maintenance sessions should continue for a longevity or detox goal. For background on the procedure itself, see how therapeutic plasma exchange works.

How many sessions did the main trials use, and what did they find?

The three trials most relevant to a series used very different schedules. None measured lifespan or disease prevention.

Trial Sessions and spacing Main finding
AMBAR, Alzheimer's (347 randomized) Weekly for 6 weeks, then monthly low-volume for 12 months Less decline on a function scale, a trend on cognition, no change in mild disease
Aging Cell, healthy adults over 50 (42) Biweekly or monthly, versus placebo Changes in epigenetic clocks; safety assessed, no clinical outcomes such as disease or lifespan measured
Long COVID (50) Six sessions versus sham No difference from sham

AMBAR: about 18 sessions over 14 months

The AMBAR trial randomized 347 patients with Alzheimer's disease to sham or one of three exchange arms. Each active arm received a 6-week period of weekly conventional exchange followed by 12 months of monthly low-volume exchange, which works out to about 18 sessions.

The trial reported 52% less decline on a daily-function scale (ADCS-ADL, P = .03) and only a trend on a cognitive scale (ADAS-Cog, P = .06), along with better scores on two global clinical scales. It found no changes in patients with mild disease, and the authors wrote that further studies are warranted. Grifols funded the trial, and six authors were full-time Grifols employees.

Aging Cell: biweekly versus monthly

This Buck Institute trial assigned 42 healthy adults over 50 to biweekly TPE with or without intravenous immunoglobulin (IVIG), monthly TPE, or placebo. It reported 15 epigenetic clocks showing rejuvenation compared with placebo, and biweekly TPE combined with IVIG proved most effective.

Epigenetic clocks estimate biological age from chemical marks on DNA. A change in a clock is not evidence of longer life or fewer diseases. The authors report only two adverse events requiring discontinuation and one related to IVIG. Three authors are members of Circulate Inc., and the author affiliations list Global Apheresis Inc., which sells TPE series. The abstract does not define "biweekly," the total session count or the trial length.

Of these three trials, it is the only one that compared schedules, and its authors listed identifying optimal regimens as a secondary goal. Because it measured biomarkers rather than clinical outcomes, it does not establish the best interval (weekly, biweekly or monthly) for any longevity goal.

Long COVID: six sessions, no benefit

A trial randomized fifty people with post-COVID condition to six sessions of TPE or sham exchange and followed them for 90 days. The authors concluded that TPE was safe but did not lead to any discernible improvement.

What is established, emerging and unproven

  • Established: TPE for specific diseases, graded one by one in the ASFA guideline, with the schedule tied to the condition. The machines are FDA-cleared, for example the Spectra Optia in 2007 and the AMICUS for plasma exchange in 2012. Clearance covers the device, not longevity use.
  • Emerging: Alzheimer's (AMBAR, mixed results), aging biomarkers (Aging Cell), and microplastics or PFAS ("forever chemicals"). The microplastics study measured levels around 174 single one-plasma-volume procedures, not across a series, and most of its authors are affiliated with Circulate Health.
  • Negative: long COVID, where six sessions were no better than sham.
  • Unproven: clinic maintenance schedules and condition-specific packages. Young-donor plasma infusion is a different procedure, and the FDA states there is no proven clinical benefit for it in preventing aging or memory loss.

How many INUSpheresis treatments are typical?

INUSpheresis clinics usually start with two treatments. It is a different procedure from TPE: plasma is filtered through a double-filtration system and returned to you rather than removed and replaced, so session counts from one method do not transfer to the other.

ELLANN Health recommends a basic cycle of two treatments within 48 hours, and says a third or fourth treatment every 6 to 7 weeks can make sense for goals such as heavy metal elimination. Biologicum Hamburg says treatment usually starts with 2 sessions.

The research behind this type of filtration is preliminary. A double-filtration study found decreases in PFAS and micro- and nanoplastic levels that varied across individuals. The authors proposed that future tissue and laboratory assays could help guide treatment frequency, and wrote that larger, well-designed clinical trials are needed. Two of the authors work at Ayus Medical Group. For more on the differences, see how INUSpheresis differs from plasma exchange.

What does a series of plasma exchange sessions cost?

US clinics list prices from $3,500 to $12,000 per session, and packages up to $59,995. In Europe, INUSpheresis runs about €2,900 per treatment at Biologicum and €5,400 to €5,700 for a two-treatment package at ELLANN.

Prices below are as listed by each clinic on November 18, 2026.

Clinic Price Sessions covered Per session
Global Apheresis, Mill Valley, CA $15,000 / $28,000 / $40,000 2 / 4 / 6 About $7,500 / $7,000 / $6,667
MDLifespan $5,995 (TPE 1 Protocol); $15,995 to $59,995 (advanced) 1–3 (TPE 1); 2–5 depending on protocol (advanced) Cannot be calculated
Neuroveda Health, Seattle $5,000 per session 1 $5,000
Extension Health, New York $12,000 per session 1 $12,000
Apeiron Center, Austin $3,500 (1-liter session); full exchange on consultation 1 $3,500, low-volume only
Biologicum Hamburg (INUSpheresis) About €2,900 per treatment Usually 2 to start About €2,900; about €5,800 for two
ELLANN Health (INUSpheresis) €5,400 to €5,700 2, plus infusions and consultation Not given separately

For wider context, see what plasma exchange costs in the US and abroad and clinic prices for TPE and INUSpheresis, with check dates.

How to compare packages and per-session prices

Divide each package by its sessions, then check how much plasma each session exchanges and what the price includes. Without all three, the prices are not comparable.

Volume matters most. Apeiron describes its 1-liter session as roughly 0.3–0.4 of your plasma volume and closer to repeated plasma donation than a full exchange. The clinic says a 1-liter session lowers plasma-phase targets by about a quarter to a third, while a full exchange of 1.0 to 1.5 plasma volumes removes roughly 63–78%. Those figures describe what leaves the plasma in one session, not a health effect.

Inclusions vary. Global Apheresis says a physician consultation is included. ELLANN's price includes accompanying infusion concepts and a preparatory medical consultation. MDLifespan says pricing depends on diagnostic testing, number of Advanced TPE sessions, and personalized support. Ask separately about IVIG, lab work, line placement, currency conversion and travel. You can compare clinics side by side.

What should you ask before committing to a series?

Ask why this number of sessions, how much plasma each one exchanges, and what result would make the clinic recommend stopping. A physician who knows your history, or your parent's, should review the answers before you pay.

Each added session repeats the same exposures. The American College of Rheumatology notes that plasmapheresis can make anemia worse and can remove some medications, including IV medications. In its hospital setting the procedure requires a central line, with a small risk of infection and bleeding. During sessions people may feel cold, nauseated, or mild tingling, and fatigue afterward is common.

Questions to ask:

  • Which study supports this number of sessions and this spacing for my goal specifically?
  • How many liters, or what fraction of my plasma volume, does each session exchange?
  • Is the replacement fluid albumin, plasma or something else? Is IVIG included or extra?
  • Will you use a peripheral line or a central line?
  • Which of my medications could be affected, and how will timing be handled?
  • What will you measure before and after, and what result would end the series?
  • What exactly does the package price include, and is any of it refundable?

Common questions

Is one plasma exchange session enough?

No trial has tested a single session for health outcomes, so there is no evidence-based answer. Extension Health says that for some conditions one or two sessions may be enough, while other clinics sell series of 4 to 6. If a clinic offers one session, ask what measurable result it is expected to change and how that will be checked afterward.

How long does each plasma exchange session take?

Most sessions take two to four hours. The American College of Rheumatology says each session lasts a few hours. Global Apheresis puts the entire session at 2–3 hours, Extension Health says 2 to 4 hours, and Apeiron says its sessions take about 2 hours. Plan a quiet rest of the day, since fatigue afterward is common.

Sources17 cited
  1. [1]Plasma Exchange (Plasmapheresis) | American College of Rheumatology · rheumatology.org
  2. [2]Therapeutic Plasma Exchange (TPE) | Global Apheresis · globalapheresis.com
  3. [3]Therapeutic plasma exchange (TPE) in Austin | Apeiron Center · apeironcenter.com
  4. [4]Therapeutic Plasma Exchange Cost | MDLifespan · mdlifespan.com
  5. [5]93 fact sheets and 183 graded and categorized indications · doi.org
  6. [6]Therapeutic Plasma Exchange NYC | Boost Energy & Immunity · extension.health
  7. [7]A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study. · doi.org
  8. [8]42 healthy adults over 50 · doi.org
  9. [9]Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial - Nature Communications · doi.org
  10. [10]510(k) Premarket Notification · accessdata.fda.gov
  11. [11]510(k) Premarket Notification · accessdata.fda.gov
  12. [12]Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? · doi.org
  13. [13]Important Information about Young Donor Plasma Infusions for Profit | FDA · fda.gov
  14. [14]ELLANN® Health I INUSpherese® · ellann-health.com
  15. [15]Inuspherese - Biologicum Hamburg · biologicum.info
  16. [16]decreases in PFAS and micro- and nanoplastic levels that varied across individuals · doi.org
  17. [17]Therapeutic Plasma Exchange | Self-Referral, Private TPE Clinic · neurovedahealth.com

For information, not medical advice. Suggest a correction · Editorial policy